InvestorsHub Logo
Followers 19
Posts 628
Boards Moderated 0
Alias Born 04/17/2013

Re: Mellowmood77 post# 212054

Saturday, 08/31/2019 12:47:17 PM

Saturday, August 31, 2019 12:47:17 PM

Post# of 425641
It's game of semantics...

The generics are claiming tha Amarin knew of EPA/DHA thus it was OBVIOUS when writing their patents.....since they were not the known inventor...

Generics are stating that Amarin was NONOBVIOUS of known effects, since the Marine 12 week study was done in yr 2010, when patents were written in 2008/2009 ,thus the patents have no specified results included when writing the patent ,thus patents are invalid.... yes filing an OBVIOUS claim that AMARIN was NONOBVIOUS of how the drug would perform....

But AMARIN was working with the FDA IN 2008/2009 on MARINE/ANCHOR studies with an SPA agreed upon.... so AMARIN knew potential results thru JELLIS STUDY but did not put those results in written patents...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News